FindTrial
Sign In

Comparison of benign and malignant body cavity effusion

Comparison of benign and malignant body cavity effusion by automated hematological analyser and flow cytometry - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069527
Enrollment
50
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C76- Malignant neoplasm of other and ill-defined sites

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Maulana Azad medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cases of body cavity effusion in individuals aged 18 years or more

Exclusion criteria

Exclusion criteria: Cases with less than 2ml or degenerated fluid.

Design outcomes

Primary

MeasureTime frame
1. Total and differential leukocyte counts in body cavity effusion 2. Proportion of cases showing expression of Ep-CAM, CD14 and CD45 in suspicious cases or cases with malignancyTimepoint: Baseline—

Secondary

MeasureTime frame
Association of cytological features (presence of reactive mesothelial cells, atypical mitosis, cytological atypia, presence of three-dimensional clusters) with clinical parameters (weight loss, biochemical parameters, radiological details, stage of the disease)Timepoint: Baseline—

Countries

India

Contacts

Public ContactArchi agrawal

Maulana Azad medical college

bemkhuraijam@gmail.com9811570454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026